MAOLATE Drug Patent Profile
✉ Email this page to a colleague
When do Maolate patents expire, and what generic alternatives are available?
Maolate is a drug marketed by Pamlab Llc and is included in one NDA.
The generic ingredient in MAOLATE is chlorphenesin carbamate. There is one drug master file entry for this compound. Additional details are available on the chlorphenesin carbamate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MAOLATE?
- What are the global sales for MAOLATE?
- What is Average Wholesale Price for MAOLATE?
Summary for MAOLATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 849 |
| DailyMed Link: | MAOLATE at DailyMed |
US Patents and Regulatory Information for MAOLATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pamlab Llc | MAOLATE | chlorphenesin carbamate | TABLET;ORAL | 014217-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
